1. Safety of Hepatitis B, Pneumococcal Polysaccharide and Meningococcal Polysaccharide Vaccines in Pregnancy

   • Marinos C. Makris
   • Konstantinos A. Polyzos
   • Matthew E. Falagas

   Review Article 20 November 2012 Pages: 1 - 14

   

2. Benefit-Risk Assessment of Bevacizumab in the Treatment of Breast Cancer

   • Rodrigo Dienstmann
   • Felipe Ades
   • Otto Metzger-Filho

   Review Article 20 November 2012 Pages: 15 - 25

   

3. Implementation of the Harmonized EU Isotretinoin Pregnancy Prevention Programme

   • Ineke Crijns
   • Sabine Straus
   • Lolkje Jong-van den de Berg

   Short Communication 20 November 2012 Pages: 27 - 32

   

4. Cardiovascular Events in Patients taking Varenicline

   • Mira Harrison-Woolrych
   • Simran Maggo
   • Janelle Ashton

   Original Research Article 20 November 2012 Pages: 33 - 43

   

5. Experiences with Adverse Drug Reaction Reporting by Patients

   • Florence van Hunsel
   • Linda Härmark
   • Kees van Grootheest

   Original Research Article 20 November 2012 Pages: 45 - 60

   

6. Identifying Adverse Events of Vaccines Using a Bayesian Method of Medically Guided Information Sharing

   • Colin John Crooks
   • David Prieto-Merino
   • Stephen J. W. Evans

   Original Research Article 20 November 2012 Pages: 61 - 78

   

7. Terminological Challenges in Safety Surveillance

   • Andrew Bate
   • Elliot G. Brown
   • Manfred Hauben

   Commentary 20 November 2012 Pages: 79 - 84

8. Glucose-6-Phosphate Dehydrogenase Deficiency and Safety of Methylene Blue

   • Olaf Müller
   • Peter Meissner
   • Ulrich Mansmann

   Correspondence 20 November 2012 Pages: 85 - 85

9. The Authors’ Reply

   • Ilan Youngster
   • Matitiahu Berkovitch

   Correspondence 20 November 2012 Pages: 85 - 86